HPV vaccination coverage in women between 15 and 55 years old in Spain: Temporal trend during the period 2007-2020

被引:3
|
作者
Ramirez, Mar [1 ]
de la Fuente, Jesus [2 ]
Andia, Daniel [3 ]
Jose Hernandez, Juan [2 ]
Fiol, Gabriel [4 ]
Torne, Aureli [5 ]
机构
[1] Univ Complutense Madrid, San Carlos Clin Hosp IdISSC, Inst Womens Hlth Jose Botella Llusia, Gynecol Oncol Unit,Sanit Res Inst, Madrid, Spain
[2] Univ Hosp Infanta Leonor, Gynecol & Obstet Dept, Madrid, Spain
[3] Basurto Univ Hosp, Gynecol & Obstet Dept, Bilbao, Spain
[4] Torrecardenas Univ Hosp, Gynecol Oncol Unit, Almeria, Spain
[5] Univ Barcelona, Hosp Clin Barcelona, Fac Med,Inst Invest Biomed August Pi I Sunyer, Inst Clin Gynecol Obstet & Neonatol,Gynecol Oncol, Barcelona, Spain
关键词
adult women; cervical cancer; cervical dysplasia; coronavirus disease 2019; HPV vaccine; human papillomavirus; vaccination coverage; vaccine acceptance; HUMAN-PAPILLOMAVIRUS VACCINATION; ADULT WOMEN;
D O I
10.1002/ijgo.14067
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The objective of this study was to analyse the temporal trend of HPV vaccination coverage (VC) in Spain in women aged 15-55 years not included in systematic vaccination programmes during the period 2007-2020. Methods We assessed the vaccine coverage rate in this population based on three estimations: 1) annual vaccination coverage with at least one dose (VCR >= 1d), 2) annual VC for the full schedule (VCR3d), and 3) cumulative VC for the full schedule (aVCR). Results Annual VCR >= 1d and VCR3d were highest in 2008 (2.40% and 0.66% respectively) and subsequently decreased drastically in 2011 (0.55% and 0.15%). From 2017 to 2019 there was an increase from 1.4-fold to 1.6-fold, respectively, which decreased in 2020. In relation to aVCR, there was an increasing trend throughout the study period with approximately 4.03% of the study population having been vaccinated against HPV in 2020. Conclusion In Spain, the cumulative vaccination coverage against HPV in women between 15-55 years old not included in current vaccination programmes remains very low. Nonetheless, the temporal trend has shown a slight increase in recent years. Despite the COVID-19 pandemic in 2020, no significant negative impact on vaccination coverage has been observed in this population.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 4 条
  • [1] Acceptability and Uptake of a Postpartum HPV Vaccination Program Among Women 15-45 Years Old
    Sao, Saumya
    Wang, Runzhi
    Thaker, Sejal
    Gingher, Erin
    Lander, Megan
    Moss, Chailee
    Chou, Betty
    Coleman, Jenell
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : 321 - 322
  • [3] Impact of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children under 15 years old in Madrid, Spain, 2007 to 2016: The HERACLES clinical surveillance study
    Picazo, Juan J.
    Ruiz-Contreras, Jesus
    Casado-Flores, Juan
    Negreira, Sagrario
    Baquero-Artigao, Fernando
    Hernandez-Sampelayo, Teresa
    Otheo, Enrique
    del Amo, Maria
    Mendez, Cristina
    Ramos, J. T.
    Betriu, C.
    Culebras, E.
    Gonzalez, F.
    Rodriguez-Avial, I
    Ruiz-Contreras, J.
    Negreira, S.
    Orellana, M. A.
    Delgado-Iribarren, A.
    Bueno, M.
    Alhambra, A.
    Garcia, M. T.
    Gonzalez, M. J.
    Cobos, J.
    Baquero, F.
    Garcia, A.
    Casado, J.
    Hernandez, B.
    Zafra, M.
    Jaqueti, J.
    Calvo, C.
    Wilhelmi, I
    Serrano, C.
    Garcia-Penuela, E.
    Cercenado, E.
    Hernandez-Sampelayo, T.
    Otheo, E.
    Ruiz, P.
    Dominguez, N.
    Gadea, I
    Romero, I
    Gomez-Garces, J. L.
    Roa, M. A.
    Ruiz, M.
    Cacho, J.
    Garcia-Picazo, M. L.
    Gallego, S.
    Cilleruelo, M. J.
    Sanchez, M., I
    Penin, M.
    Gomez, P.
    [J]. VACCINE, 2019, 37 (16) : 2200 - 2207
  • [4] DECLINE IN SERUM ANTI MULLERIAN HORMONE LEVELS AND INCREASE OF SERUM PROLACTIN LEVELS IN YOUNG NORTH AFRICAN WOMEN AGED BETWEEN 25 AND 35 YEARS OLD DURING THE PERIOD BETWEEN 2013 AND 2021
    Benkhalifa, Mustapha
    Zidi, Wiem
    Bahri, Hatem
    [J]. FERTILITY AND STERILITY, 2023, 120 (04) : E321 - E321